Fixed drug eruptions in children

J G Morelli; Y K Tay; M Rogers; A Halbert; B Krafchik; W L Weston

doi:10.1016/s0022-3476(99)70472-5

Fixed drug eruptions in children

J Pediatr. 1999 Mar;134(3):365-7. doi: 10.1016/s0022-3476(99)70472-5.

Authors

J G Morelli¹, Y K Tay, M Rogers, A Halbert, B Krafchik, W L Weston

Affiliation

¹ Department of Dermatology, University of Colorado School of Medicine, Denver, Colorado 80262, USA.

PMID: 10064679
DOI: 10.1016/s0022-3476(99)70472-5

Abstract

To determine the anatomic location and offending drug in fixed drug eruptions (FDE) in children, we performed a 5-year retrospective analysis. Thirty-five children with FDE were evaluated. The most common cause of FDE was the combination drug trimethoprim-sulfamethoxazole.

Publication types

Multicenter Study

MeSH terms

Adolescent
Analgesics, Non-Narcotic / adverse effects
Anti-Bacterial Agents / adverse effects
Anti-Infective Agents / adverse effects
Child
Child, Preschool
Drug Eruptions / diagnosis*
Drug Eruptions / etiology
Female
Humans
Infant
Retrospective Studies
Sulfonamides / adverse effects
Trimethoprim, Sulfamethoxazole Drug Combination / adverse effects

Substances

Analgesics, Non-Narcotic
Anti-Bacterial Agents
Anti-Infective Agents
Sulfonamides
Trimethoprim, Sulfamethoxazole Drug Combination